Cough with ACE inhibitors: A bigger problem in some racial groups?

Cardiovascular Drugs and Therapy

Volumn 19, Issue 3, 2005, Pages 173-175

  Nicholls, M Gary ^a   Gilchrist, Nigel L ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b PRINCESS MARGARET HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL;

BLOOD TESTIS BARRIER; COUGHING; DISEASE COURSE; EDITORIAL; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; HYPERTENSION; MALE FERTILITY; MEDICAL ASSESSMENT; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COUGH; HUMANS;

EID: 24344450768     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-005-2501-9     Document Type: Editorial

References (30)

1. Reisin L, Schneeweiss A. Spontaneous disappearance of cough induced by angiotensin-converting enzyme inhibitors (captopril or enalapril). Am J Cardiol 1992;70:398-399.
2. Lip GY, Zarifis J, Beevers M, Beevers DG. Duration of cough following cessation of ACE inhibitor therapy. Am J Hypertens 1995;8:98.
3. Malini PL, Strocchi E, Zanardi M, Milani M, Ambrosioni E. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997;350: 15-18.
4. Umemura K, Nakashima M, Saruta T. Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors. Life Sci 1997;60:1583-1588.
5. Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. Bradykinin-evoked sensitization of airway sensory nerves: A mechanism for ACE-inhibitor cough. Nat Med 1996;2:814-817.
6. Lacourciere Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. J Hypertens 1994;12:1387-1393.
7. Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet 1998;352:1069.
8. Okaishi K, Morimoto S, Fukuo K, et al. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens 1999;12:778-783.
9. Arai T, Yasuda Y, Takaya T, et al. ACE inhibitors and reduction of the risk of pneumonia in elderly people. Am J Hypertens 2000;13:1050-1051.
10. El Solh AA, Brewer T, Okada M, Bashir O, Gough M. Indicators of recurrent hospitalization for pneumonia in the elderly. J Am Geriatr Soc 2004;52:2010-2015.
11. Chan WK, Chan TYK, Luk WK, Leung VKS, Li TH, Critchley JAJH. A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol 1993;44:299-300.
12. Woo KS, Norris RM, Nicholls G. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol 1995;75:967-968.
13. Morimoto T, Gandhi TK, Fiskio JM, et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004;10:499-509.
14. Morimoto T, Gandhi TK, Fiskio JM, et al. Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough. J Gen Intern Med 2004;19:684-691.
15. Yeo WW, Foster G, Ramsay LE. Prevalence of persistent cough during long-term enalapril treatment: Controlled study versus nifedipine. Q J Med 1991;81:763-770.
16. Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am. J Hypertens 1994;7:1012-1015.
17. Efstratopoulos AD, Meikopoulos M, Voyaki S. Frequency of cough during therapy with ACE inhibitors in Greek hypertensives. J Hum Hypertens 1993;7:607-609.
18. Fisman EZ, Grossman E, Motro M, Tenenbaum A. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors. J Hum Hypertens 2002;16:379-383.
19. Nicholls MG, Gilchrist NL. Sulindac and cough induced by converting enzyme inhibitors. Lancet 1987;1:872.
20. Fuller RW. Cough associated with angiotensin-converting enzyme inhibitors. J Hum Hypertens 1989;3:159-161.
21. Gilchrist NL, Richards AM, March R, Nicholls MG. Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: Randomised placebo-controlled double-blind cross-over study. J Hum Hypertens 1989;3:451-455.
22. Fogari R, Zoppi A, Tettamanti F, Malamani GD, Tinelli C, Salvetti A. Effects of nifedipine and indomethacin on cough induced by angiotensin- converting enzyme inhibitors: A double-blind, randomized, cross-over study. J Cardiovasc Pharmacol 1992;19:670-673.
23. Ohya Y, Kumamoto K, Fujishima M. Effects of crossover application of sulindac and azelastine on enalapril-induced cough. J Hum Hypertens 1992;6:81-82.
24. Malini PL, Strocchi E, Fiumi N, Ambrosioni E, Ciavarella A. ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care 1999;22:1586-1587.
25. Lee Y-J, Tsai JCR. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor-58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 2001;50:1346-1350.
26. Ogihara T, Mikami H, Katahira K, Otsuka A. Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex. Am J Hypertens 1991;4:46S-51S.
27. Sasaguri M, Ideishi M, Kinoshita A, Arakawa K. Differential inhibition of bradykinin hydrolysis by four ACE Inhibitors: A possible explanation for differences in induced coughing. Hypertens Res 1994;17:253-258.
28. Yeo WW, Ramsay LE. Persistent dry cough with enalapril: Incidence depends on method used. J Hum Hypertens 1990;4:517-520.
29. Fletcher AE, Palmer AJ, Bulpitt CJ. Cough with angiotensin converting enzyme inhibitors: How much of a problem? J Hypertens 1994;12(Suppl 2):S43-S47.
30. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996;60:8-13.